Jasper Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Jasper Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2020 to Q2 2024.
  • Jasper Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 978 %, a 11.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 978 -123 -11.2% Jun 30, 2024
Q1 2024 1.03K +27.1 +2.72% Mar 31, 2024
Q4 2023 1.08K +228 +26.7% Dec 31, 2023
Q3 2023 1.11K +121 +12.3% Sep 30, 2023
Q2 2023 1.1K +1.66 +0.15% Jun 30, 2023
Q1 2023 1K -127 -11.2% Mar 31, 2023
Q4 2022 854 -228 -21.1% Dec 31, 2022
Q3 2022 989 +81 +8.91% Sep 30, 2022
Q2 2022 1.1K +614 +126% Jun 30, 2022
Q1 2022 1.13K +617 +121% Mar 31, 2022
Q4 2021 1.08K +558 +106% Dec 31, 2021
Q3 2021 908 +205 +29.1% Sep 30, 2021
Q2 2021 486 Jun 30, 2021
Q1 2021 509 Mar 31, 2021
Q4 2020 524 Dec 31, 2020
Q3 2020 704 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.